Cello Health

Cello Health are a passionate team of global advisers, expert at navigating life science clients to confident critical decisions

Join our team

We are always on the lookout for great people who want to do things on the cutting edge of science and technology

Join us

Teams of experts

We are expert navigators helping guide our clients to more successful outcomes

Our people

With a global perspective

We work with 24 of the top 25 pharmaceutical companies as well as 100s of biotechs globally from our offices in the US and Europe

Our locations

Giving back

We support a variety of causes across our global business

Giving back

We provide multiple perspectives, helping healthcare clients uncover hidden insights, explore scientific options and make difficult strategic choices

We recognise that the journey is often as important as the destination. We work like an extension of your team so your overall journey with us feels better

How we work What we do
We provide multiple perspectives, helping healthcare clients uncover hidden insights, explore scientific options and make difficult strategic choices

Read our latest News & Views >

Cello Health and BresMed join forces to support value demonstration and optimise patient access for new biopharma therapies
09 February 2021 news
Cello Health and BresMed join forces to support value demonstration and optimise patient access for new biopharma therapies

Cello Health and BresMed join forces to support value demonstration and optimise patient access for new biopharma therapies

WHITE PAPER – Biotech and Breakthroughs in Immuno-Oncology
19 January 2021 views
WHITE PAPER – Biotech and Breakthroughs in Immuno-Oncology

White paper by Jeffrey M. Bockman, PhD. Biotech and Breakthroughs in Immuno-Oncology

EVENT – Cancer Progress, Virtual | May 4-6 2021
19 January 2021 views
EVENT – Cancer Progress, Virtual | May 4-6 2021

Join us at Cancer Progress, Virtual May 4-6 2021 ❝ Inspiring Cancer Progress through engaged stakeholder dialogue ❞

WHITE PAPER – Early Asset Commercialization Strategy: The Time is Now
19 January 2021 views
WHITE PAPER – Early Asset Commercialization Strategy: The Time is Now

The biotech industry is in an exciting period of growth and innovation, the number of new products being registered continues to increase year on year, with a significant proportion of these being novel, first in class medicines.

Let’s work together

The journey to scientific and commercial success is often complex and always critical. If you are looking for an expert partner to help steer you to confident solutions, contact us today

Contact us